Diuretics in the management of chronic heart failure: when and how

Joseph S Magdy1,2, James McVeigh1,2, Praveen Indraratna1,2

  • 1Department of Cardiology, Prince of Wales Hospital, Sydney.

Australian Prescriber
|December 8, 2022
PubMed

Insights

Diuretics are crucial for managing fluid overload in heart failure patients, even with newer treatments. Understanding diuretic use, dosage, and monitoring is essential for effective heart failure care.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Heart failure (HF) is a growing global health concern with high rates of hospitalization, mortality, and morbidity.
  • While advancements in HF management include drugs with proven mortality benefits for reduced ejection fraction, clinical congestion remains a challenge.

Purpose of the Study:

  • To emphasize the continued importance of diuretics in managing clinical congestion across all HF types.
  • To highlight the critical role of clinicians in optimizing diuretic therapy for heart failure patients.

Main Methods:

  • Review of current heart failure management guidelines and pharmacological principles.
  • Analysis of the role of diuretics in symptomatic relief and fluid management in heart failure.

Main Results:

  • Guideline-directed therapies are paramount, but diuretics remain indispensable for managing fluid overload.
  • Effective use of diuretics requires careful attention to dosing and patient monitoring.

Conclusions:

  • Diuretics are a cornerstone therapy for symptomatic management of congestion in heart failure.
  • Clinician expertise in diuretic selection, titration, and monitoring is vital for successful heart failure treatment.

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
448
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
19
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
24
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
130
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
482
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
26